NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today announced a new partnership with The Aesthetic ...
Healthcare data and intelligence provider Guidepoint Qsight today released its latest report on neurotoxin use in the U.S., Qsight Flash Report: Generational Neurotoxin Use Across the United States.
Healthcare data and intelligence provider Guidepoint Qsight has launched its new social media insights platform, Qsight Social Intelligence. Based on proprietary technology developed by Guidepoint ...
NEW YORK, May 24, 2021 /PRNewswire/ — Guidepoint Qsight’s (R) data, which includes proprietary point-of-sale and survey data from hundreds of med spas and physician practices in the U.S., captured a ...
New Dashboard Provides Data-Driven Insights on Treatment Pairings and Cross-Purchasing Over Time Analyzes rates of cross-purchasing between medical aesthetic procedures, treatments, and products ...
WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--(analytica Booth #N2, 2100) PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its new QSightâ„¢ ...
Ideal for analyzing food, cannabis, and environmental samples, our robust and reliable QSight® triple quad systems consistently deliver the throughput and productivity you need in your analytical ...
Qsight estimates $6.4 Billion in total patient spend on neurotoxins in 2024 31% of non-surgical aesthetic spending was on neurotoxins, an 8% increase over 2023 Millennials closing the gap with Gen X ...
New York, NY, USA, May 28, 2026 (GLOBE NEWSWIRE) -- New Dashboard Provides Data-Driven Insights on Treatment Pairings and Cross-Purchasing Over Time Analyzes rates of cross-purchasing between medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results